Hormonal therapy for breast cancer recurrence: What you need to know?

Breast cancer is a serious medical condition that affects millions of women worldwide. While the incidence rates of breast cancer have increased over the years, the survival rates for breast cancer have also seen a steady increase thanks to advancements in treatment options. One of these treatment options is Hormonal Therapy.

Hormonal Therapy is a type of treatment that works by preventing certain hormones, such as estrogen or progesterone, from promoting the growth of breast cancer cells. This therapy is particularly useful for treating breast cancers that are hormone receptor-positive, meaning that the cancer cells have receptors for either estrogen or progesterone. Hormonal Therapy can be used to reduce the risk of breast cancer recurrence after initial treatment, or as a primary treatment method for breast cancer.

There are three types of Hormonal Therapy typically used to treat breast cancer: Selective Estrogen Receptor Modulators (SERMs), Aromatase Inhibitors (AIs), and Selective Estrogen Receptor Downregulators (SERDs).

SERMs work by binding to estrogen receptors in cancer cells, preventing estrogen from promoting further growth of the cancer. Tamoxifen is the most commonly used SERM, and is commonly prescribed for premenopausal and postmenopausal women with estrogen receptor-positive breast cancer.

AIs work by blocking aromatase enzymes, which are responsible for producing estrogen in the body. This reduces the amount of estrogen available to cancer cells, thus inhibiting their growth. AIs are typically prescribed for postmenopausal women with estrogen receptor-positive breast cancer. Common AIs include Anastrozole, Letrozole, and Exemestane.

SERDs work by binding to estrogen receptors in cancer cells and blocking their activity, effectively shutting down the estrogen receptor entirely and preventing it from promoting further cancer growth. The most commonly used SERD is Fulvestrant.

Hormonal Therapy has been shown to be a highly effective treatment method for hormone receptor-positive breast cancer, reducing the risk of recurrence and increasing overall survival rates. However, it does come with some common side effects that patients should be aware of.

The most common side effects of Hormonal Therapy include hot flashes, vaginal dryness, changes in menstrual cycles, nausea, and fatigue. SERMs, in particular, can increase the risk of blood clots and endometrial cancer. AIs can cause bone loss and joint pain. SERDs can cause nausea, vomiting, and headaches.

Patients undergoing Hormonal Therapy should discuss these potential side effects with their healthcare team and work together to manage them as necessary.

In conclusion, Hormonal Therapy is an effective treatment method for hormone receptor-positive breast cancers. Patients should work closely with their healthcare team to determine if Hormonal Therapy is the right treatment option for them, and to manage any potential side effects. With the help of Hormonal Therapy, patients can increase their chances of a full recovery from breast cancer and move forward with their lives with greater hope and optimism.

¡Surprise Me!